Biologics

BoneSupport TM extends U.S. Distribution agreement for Cerament TM Bone Void Filler
Biologics Top Stories

BoneSupport TM extends U.S. Distribution agreement for Cerament TM Bone Void Filler

Lund, Sweden, 14 March, 2017 – BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease or related surgery, announces that it has extended the term of its U.S. distribution agreement with Zimmer Biomet.  Under the agreement, Zimmer Biomet will continue […]

Histogenics Announces Publication of Biomechanical and Structural Data From Human Engineered Cartilage Testing
Biologics

Histogenics Announces Publication of Biomechanical and Structural Data From Human Engineered Cartilage Testing

WALTHAM, Mass., March 09, 2017 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, today announced the online publication in the Journal of Orthopaedic Research of a peer-reviewed publication entitled Mechanical Properties and Structure-Function Relationships of Human Chondrocyte-Seeded […]

Bio2 Technologies, Inc. to Present Results from Ovine Spinal Fusion Study
Biologics Spine Top Stories

Bio2 Technologies, Inc. to Present Results from Ovine Spinal Fusion Study

WOBURN, Mass., March 8, 2017 /PRNewswire/ — Bio2 Technologies will present a poster at the Annual Meeting of the Orthopaedic Research Society (http://www.ors.org) in San Diego, CA on March 22, 2017 reporting the results from an ovine interbody fusion study conducted at Colorado State University comparing Bio2’s Vitrium device to […]

Bone Therapeutics Strengthens Clinical Development Leadership with Appointment of Dr. Miguel Forte as Chief Medical Officer
Biologics Top Stories

Bone Therapeutics Strengthens Clinical Development Leadership with Appointment of Dr. Miguel Forte as Chief Medical Officer

March 06, 2017 GOSSELIES, Belgium–(BUSINESS WIRE)–Regulatory News: BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces the appointment of Miguel Forte, MD, PhD as Chief Medical Officer (CMO). Dr. Forte has significant regenerative […]

Cellular Biomedicine Group Awarded $2.29 Million Grant from the California Institute for Regenerative Medicine (CIRM)
Biologics Financial

Cellular Biomedicine Group Awarded $2.29 Million Grant from the California Institute for Regenerative Medicine (CIRM)

SHANGHAI, China and CUPERTINO, Calif., Feb. 27, 2017 (GLOBE NEWSWIRE) — Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of effective immunotherapies for cancer and stem cell therapies for degenerative diseases, announced today that the governing Board of the California Institute for […]

Amedica Announces Results of Independent Femoral Head Wear Testing
Biologics

Amedica Announces Results of Independent Femoral Head Wear Testing

SALT LAKE CITY, UT–(Marketwired – Feb 27, 2017) – Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, announced today that Researchers from the Department of Orthopaedic Surgery of Tokyo Medical University (Shinjuku-ku, Tokyo, Japan) led by Professor Kengo […]

Orthobiologics Market to Reach $10.2 Billion by 2025
Biologics

Orthobiologics Market to Reach $10.2 Billion by 2025

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Orthobiologics Market 2014 – 2025” report to their offering. The global orthobiologics market is expected to reach USD 10.2 billion by 2025. The orthobiologics market is predominantly driven by the increasing orthopedic disease and musculoskeletal disease burden globally. Moreover, emerging […]